Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€502.50
17.08.23
17.08.23
€510.00
17.08.24
17.08.24
10.75%
13.09.23
13.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€388.00
05.05.23
05.05.23
€395.00
05.05.24
05.05.24
3.52%
12.05.23
12.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€407.05
24.01.22
24.01.22
€418.00
24.01.23
24.01.23
10.66%
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.70
27.11.21
27.11.21
€160.00
27.11.22
27.11.22
21.35%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Humana Inc.
Start price
Target price
Perf. (%)
€390.10
20.10.21
20.10.21
€460.00
31.12.23
31.12.23
25.56%
01.09.22
01.09.22
Could be very worthwhile Investment >20% year
Anthem Inc.
Start price
Target price
Perf. (%)
€363.90
20.10.21
20.10.21
€400.00
31.12.23
31.12.23
26.90%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€373.45
20.10.21
20.10.21
€450.00
31.12.23
31.12.23
28.49%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€158.36
17.06.21
17.06.21
€165.00
17.06.22
17.06.22
59.60%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Centene Corp.
Start price
Target price
Perf. (%)
€51.00
01.05.21
01.05.21
€56.00
01.05.22
01.05.22
50.31%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€101.00
09.03.21
09.03.21
€120.00
09.03.22
09.03.22
19.46%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year